Introduction. Stroke is one of the leading causes of morbidity and mortality. Cardiac troponins have been found to be increased in other conditions apart from the cardiac diseases, such as stroke. The aim of the study was to assess the correlation between elevated troponin I levels and stroke outcome.
INTRODUCTION
Cardiovascular disease is the leading cause of death in Europe [1] . Stroke is a leading cause of disability and the third cause of mortality in the world; central and particularly eastern European countries still have high incidence and prevalence of stroke [2, 3] .
Cardiac troponins are regulatory proteins unique and completely specific to the myocardium, and are an ideal marker of myocardial damage due to their extremely low circulating levels in normal individuals [4] . Cardiac troponin is nowadays central to the definition of acute myocardial infarction (MI) in the consensus guidelines from several major organizations [5] . Although the elevation of cardiac troponins in the blood indicates the presence of myocardial necrosis, the underlying mechanism of necrosis is not certain, as elevated troponin levels can be present in various other clinical conditions causing predominantly nonischemic myocardial injury [5] . The correlation between elevated cardiac troponin levels and stroke outcome has not been elucidated thoroughly yet.
The aim of our study was to assess the correlation between increased troponin I levels and outcome in stroke patients.
METHODS
This retrospective study included consecutive patients with acute ischemic stroke who were admitted to the Department of Neurology, Sveti Duh University Hospital, Zagreb, Croatia, from 2007 to 2010 in whom troponin I levels were obtained on admission (up to 72 hours after stroke symptoms). The cut-off point for increased levels was set at 0.5 µg/L. Patients were divided into two groups according to troponin I cut-off point: group with normal troponin I levels (<0.5µg/L) and group with elevated troponin I levels (≥0.5 µg/L). The local ethics committee approved the study.
Patients were assessed using standard clinical and radiological methods. Data on patients' comorbidities and ischemic stroke subtype according to TOAST classification were collected. Stroke outcome was assessed using modified Rankin Scale (mRS) at hospital discharge and in-hospital mortality data. Unfavorable outcome is defined by a mRS score >2.
Exclusion criteria were concomitant acute coronary syndrome, severe congestive heart failure, pulmonary embolism, renal failure, rhabdomyolysis and septic conditions (sepsis, endocarditis, myocarditis…). 20 All data was analyzed using Microsoft Excel, and Fisher's exact test, t-test and other values were obtained where necessary using GraphPad.
RESULTS
The troponin I levels were obtained at admission for 198 patients. In the group with elevated troponin I levels were 10 cases (5.05%), mean 1.70 ± 1.54 ng/mL, and median 1.24 ng/mL. Mean value in the group with normal troponin I levels was 0.05 ± 0.03 ng/mL, median 0.03 ng/mL. There were only two patients excluded from the study because of simultaneous stroke and acute coronary syndrome. Their troponin values were 3.09 and 64.12, respectively. Table 1 shows some of the patients' characteristics. No statistically significant differences were found between groups regarding age, gender, stroke risk factors and subtypes, while there was a statistically significant difference in the proportion of prior ischemic stroke between two groups, as they were more common in the group with elevated troponin I levels. There was a statistically significant difference in modified Rankin Scale scores (mRS) and in-hospital mortality between the groups ( Table 2) . 
DISCUSSION
In our study, we found a statistically significant association between increased troponin I levels and adverse outcome, in both higher in-hospital mortality and higher modified Rankin Scale score at hospital discharge. Stroke poses an increased risk for electrocardiographic changes, cardiac arrhythmias, and myocardial cell damage [6] . It has been shown that highly specific myocardial necrosis markers such as troponin can be increased in stroke victims, a phenomenon that has been explained by several pathophysiologic mechanisms: primary cardiac damage with secondary cardioembolic cerebral ischemia or primary cerebral ischemia with secondary cardiac damage caused by increased levels of catecholamines (caused by sympathetic system activation) [7] [8] [9] [10] . Some studies associate increased troponin levels with a certain localization of stroke: insular or right hemisphere [11] [12] [13] . Atrial fibrillation is more likely to be diagnosed after a detailed evaluation in patients with troponin increase [14] .
The proportion of stroke patients with cardiac troponin level increase varies in several studies from 9.73% to 20.6% [11, 12, 15] . However, a smaller proportion of patients had increased troponin I levels in our study probably because higher cut-off levels were used. The lack of difference between the groups in our study in the proportion of patients diagnosed with atrial fibrillation could be explained with insufficient follow-up, or the fact that some of the patients who possibly had atrial fibrillation died before it could be verified.
These findings are consistent with a previous study by Lasek-Bal et al., who have found that elevated levels of troponin I are present in less than 10% of patients, and these patients were associated with an unfavorable course of stroke leading to significant disability and less independence in their activities of daily living. In their study the cut-off level for troponin I was 0.014 ng/mL [11] . Scheitz et al.'s study has found that the elevation of troponin T levels occurs in every seventh patients with acute ischemic stroke and is indepedently associated with poor short-term outcome measured by mRS (mRS >2) and in-hospital mortality [15] . Furthermore, elevated troponin levels are associated with an almost 2-fold increased risk of 5-year mortality [16] . In concordance with our study several studies showed that the short-term and long-term unfavorable outcome has been associated with increased troponin levels [6, 11, 12, [15] [16] [17] .
As opposed to levels of troponin I elevation found in our study, cardiac causes of troponin elevation are usually associated with higher troponin I levels [18] .
Several prior studies have shown inconsistent results: a considerable number of previous studies showed similar, as well as discordant findings and results for most parameters assessed in this study. The limitations of our study include the fact that it is a single center study, and that we were not focused on initial stroke severity. Caution is needed when interpreting the result due to a relatively small number of patients, and a possible selection bias inherent to the way participants were enrolled.
CONCLUSION
Our study showed that patients with high initial troponin I levels are associated with unfavorable outcome or death. Further investigation is necessary to clearly show the association of troponin I levels and stroke outcome. Stroke may be associated with mild elevation of troponin levels, contrary to higher levels which are usually related to other conditions. Acknowledgements. None. 
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